FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

414806008: Natalizumab 300mg injection solution 15mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2531807010 Natalizumab 300mg injection solution 15mL vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
    2535363012 Natalizumab 300mg injection solution 15mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module
    2538012018 Natalizumab 20mg/mL injection solution 15mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module
    2538013011 Natalizumab 300mg/15mL injection solution en Synonym Active Only initial character case insensitive SNOMED CT core module
    53212901000001112 Natalizumab 300mg/15ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Natalizumab 300mg injection solution 15mL vial Is a Product containing natalizumab false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has active ingredient Natalizumab false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has specific active ingredient Natalizumab false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Natalizumab 300mg injection solution 15mL vial Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Tysabri 300mg/15ml concentrate for solution for infusion vials (Biogen Ltd) Is a False Natalizumab 300mg injection solution 15mL vial Inferred relationship Existential restriction modifier
    Natalizumab 300mg/15ml solution for injection vials 1 vial Is pack of False Natalizumab 300mg injection solution 15mL vial Inferred relationship Existential restriction modifier
    Natalizumab 300mg/15ml solution for injection vials 1 vial Has VMP False Natalizumab 300mg injection solution 15mL vial Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start